Europe

Techne buys Tocris Holdings

Tuesday, May 3, 2011 01:16 PM

U.K. based Techne Corporation has acquired 100% ownership of another U.K.-based company, Tocris Holdings, a leading supplier of reagents for non-clinical life science research.  Tocris' products are used in both in-vitro and in-vivo experiments, to understand biological processes and diseases. The business is focused on making biologically active neuro- and bio-chemicals which are used by researchers to elucidate biological processes and pathways. The products are used in life-science research activities and as part of the initial drug discovery process.

More... »

Evotec acquires Kinaxo Biotechnologies

Tuesday, April 19, 2011 11:28 AM

Germany-based Evotec has acquired of Kinaxo Biotechnologies, a drug discovery business with particular expertise in oncology. Completion of the deal gives Evotec access to technologies in drug discovery, efficacy, response predication, and safety assessment.

More... »

Warner to cut 500 jobs

Monday, April 18, 2011 01:28 PM

After losing patent protection on their osteoporosis drug Actonel, Ireland-based Warner Chilcott is restructuring its E.U. operations and plans to cut 500 jobs in the process, according to Fierce Pharma. Actonel brought in about 70% of Warner's sales in Western Europe in 2010, and the drug is up against generic competition.

More... »

Almac named “Business of the Year”

Monday, April 18, 2011 12:09 PM

Almac, a drug development services company headquartered in Craigavon Northern Ireland, was named ‘Business of the Year’ at the Northern Ireland business awards, run by the nation’s main daily newspaper, The Belfast Telegraph.

More... »

CROM acquires CRO MSOURCE

Monday, April 18, 2011 11:44 AM

CROM a CRO headquartered in Verona, Italy, has acquired CRO MSOURCE, creating a new company called CROMSOURCE.  The new CRO offers international coverage and a range of clinical research services and staffing solutions.

More... »

Plasticell demerges to create regenerative drug discovery unit

Wednesday, April 13, 2011 12:41 PM

London-based Plasticell, the biotechnology company developing stem cell technologies, has undergone a strategic re-structuring to enable the company to focus on its award winning CombiCult technology for stem cell differentiation. Consequently, Plasticell has demerged its regenerative drug discovery unit into a newly established company, Progenitor Labs.

More... »

Researchers reveal GR and depression link

Wednesday, April 13, 2011 12:38 PM

Scientists in the U.K. using human stem cells say they have discovered how certain antidepressants form new brain cells, according to a Reuters report.  This finding will help researchers develop more effective drugs for treating depression.

More... »

Medivir to acquire BioPhausia

Tuesday, April 12, 2011 11:18 AM

Swedish pharmaceutical company Medivir will acquire BioPhausia, another Sweden-based firm, in a deal that will "create a platform" for its hepatitis C treatment, according to Pharma Times.

More... »

Astellas Pharma Europe appoints Ken Jones as president and CEO

Monday, April 11, 2011 12:34 PM

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Ken Jones as its president and CEO.  Jones was formerly COO at Astellas Pharma Europe.

More... »

Takeda's Trevor Smith assumes role of CEO

Thursday, April 7, 2011 11:46 AM

Takeda Pharmaceutical’s Trevor Smith, currently vice president, International Strategy, will assume the role of chief executive officer of Takeda Pharmaceuticals Europe for oversight of pan-European sales and marketing.

More... »